Experience

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 1.250% U.S. dollar bonds due 2019 issued by Export Development Canada. Export…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Novavax, Inc. of an aggregate principal amount of …

Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by Abbott Laboratories. The transaction is subject to the approval of…

Davis Polk is advising JP Morgan as financial adviser to Stryker Corporation in connection with its $2.775 billion acquisition of Sage Products, LLC from Madison Dearborn Partners. The…

Davis Polk advised underwriters in connection with the offering of C$750 million aggregate principal amount of 1.95% bonds due January 27, 2023, issued by the Province of Ontario. The net…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $5.5 billion aggregate principal amount of senior notes, consisting of $2 billion 2.450% fixed…

Davis Polk advised the joint lead managers in connection with the offering of $1.75 billion aggregate principal amount of 1.875% notes due 2019 by Dexia Crédit Local as issuer and the…

Davis Polk is advising the joint lead arranger, bookrunner and administrative agent for a $100 million superpriority secured debtor-in-possession ABL credit facility (with a $50 million…

Davis Polk advised the joint bookrunners in connection with an offering of 2,200,000 shares of common stock of Signature Bank. The shares were offered pursuant to Section 3(a)(2) of the…

Davis Polk advised the joint book-running managers in connection with an SEC-registered common stock offering of 16,100,000 shares of common stock of Synergy Resources Corporation. Included…